Isolated DNA Cannot Be Patented, High Court Rules

Law360, New York (June 13, 2013, 11:33 AM EDT) -- Human genes cannot be patented, the U.S. Supreme Court ruled Thursday, striking down Myriad Genetics Inc.'s patents on isolated DNA associated with an increased risk of breast cancer.

In a unanimous decision written by Justice Clarence Thomas, the high court concluded that Myriad's patents cover a law of nature that cannot be patented under Section 101 of the Patent Act, siding with the American Civil Liberties Union and other groups that challenged the patents.

"We hold that a naturally occurring DNA segment is a product of...
To view the full article, register now.